1208: IMPACT OF ENOXAPARIN ON ANTI-XA LEVELS WHEN TRANSITIONING TO UNFRACTIONATED HEPARIN INFUSIONdoi:10.1097/01.ccm.0001002996.84540.16Miranda GrahamGeisinger Medical Center, Danville, PAAmber LinkhorstLehigh Valley Health NetworkLaura AndrickGeisinger Medical Center, Danville, PA...
This study assessed the relationships between rivaroxaban-specific anti-factor Xa activity (AXA) and unfractionated heparin (UFH)-specific AXA and determined the cutoff level for UFH-specific AXA in critical situations for patients undergoing rivaroxaban therapy. Methods Thirty-eight blood samples were ...
Monitoring Unfractionated Heparin (UFH) therapy: Which Anti Factor Xa assay is appropriate? Anti-Factor Xa (Anti-Xa) assays specifically determine the anticoagulant activity of UFH by measuring the ability of heparin-bound Antithrombin (AT) to inh... V Ignjatovic,R Summerhayes,A Gan,... - 《...
anti-Xa assayexternal quality assurancelow-molecular weight heparinunfractionated heparinAlthough there is considerable debate regarding the usefulness of laboratory... Bonar,A Roslyn - 《Seminars in Thrombosis & Hemostasis》 被引量: 15发表: 2012年 Stability of low molecular weight heparins stored in ...
Safety and Effectiveness of an Anti-Xa-based Unfractionated Heparin Protocol for Impella Percutaneous Ventricular Assist Devices Results: Anti-Xa values were in therapeutic range 46% of the time while on support (interquartile range 16.6%-75%), with a median IV UFH dose of ... SE Berman,L ...
Anti-factor Xa Microdialysis Microfluidic Real-time monitoring Therapeutic drug monitoring Abbreviations UFH unfractionated heparin LMWH low molecular weight heparin 1. Introduction Vascular thrombosis can occur in both arterial and venous circulation and is the leading cause of cardiovascular morbidity and mor...
The discovery and clinical application of heparin have signifi-cantly improved the outcomes in numerous aspects of serious medi- cal conditions. In this light, several heparin-based agents, such as unfractionated heparin (UFH) and low molecular weight heparin (LMWH), are included in World Health...
Although the activated partial thromboplastin time (aPTT) has historically been the method of choice for anticoagulation monitoring in patients undergoing mechanical circulatory support with intravenous unfractionated heparin, it is being progressively superseded by the anti-factor Xa (anti-Xa) method. A ...
Unfractionated and low molecular weight heparins have been shown to be equally beneficial in the treatment of women with PAPS, the latter having the advantage of being a once daily injection. Women may also be reassured that the modest loss in BMD observed with heparin therapy is not ...
Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time: a rebuttalInterlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time: a rebuttaldoi...